Professor Stephen Bustin BA PhD
Professor of Molecular Medicine, Institute of Cell and Molecular Science, Queen Mary University of London. Stephen is a leading researcher in the genetic determinants of colonic cancer, and heads a large and productive research team, with more than 70 research papers to his name. He is one of the most highly regarded international figures in PCR gene analysis, and has written what is generally regarded as the definitive textbook in this area. He organises meetings throughout the world for researchers in this field, and is at the very forefront of new developments in genetic analysis.
< Back

Dr David Brull  MBBS, BSc, MRCP, MD
Dr Brull qualified from the Royal Free Hospital Medical School in 1992 and has since worked in several London teaching hospitals (Guys Hospital, The Royal Free and University College London Hospitals) before being appointed as Consultant Cardiologist and Honorary Senior Lecturer to The Whittington Hospital and The Heart Hospital, UCLH in October 2003. His main clinical interests are in coronary intervention (angioplasty and stenting) and the genetics of cardiovascular disease. He has an MD thesis from the Cardiovascular Genetics Department at University College, London and has published a number of scientific research papers primarily focussing on aspects of gene-environment interaction in cardiovascular disease and the genetics of the inflammatory response.
< Back

Dr Mel Lobo  MB ChB PhD MRCP
Dr Lobo qualified in medicine from the University of Manchester in 1989 and was appointed as Consultant Physician in Cardiovascular Medicine and Clinical Pharmacology at St Bartholomew’s & The London NHS Trust in 2002. He was awarded a PhD in Cell Biology in 2000 from the University of London. Dr Lobo has specialist interests in cardiovascular risk factor modification and the influence of genetic mechanisms on this. He is an honorary Senior Lecturer in the William Harvey Research Institute and has an academic interest in the field of pharmacogenomics. He is a member of the Trust new Drugs Group and Medicine Safety Group.
< Back

Professor Mark McCarthy

Mark McCarthy is Robert Turner Professor of Diabetes at the University of Oxford. In parallel with his training as a consultant physician in Diabetes and Endocrinology, he developed a research interest in the genetics of complex traits receiving training from, amongst others, Newton Morton and Eric Lander. Working with national and international collaborators he has pioneered large-scale approaches to susceptibility gene discovery in type 2 diabetes and related traits. Most recently, as part of the Wellcome Trust Case Control Consortium his group has used genome-wide association approaches to identify the first common genetic variants influencing adult weight and risk of obesity, and to add substantially to the number of genetic regions involved in type 2 diabetes. Indeed, his group have contributed to the discovery and/or primary replication of 10 of the 11 genes currently confirmed as playing a role in susceptibility to type 2 diabetes. As well as continuing efforts at gene discovery, his group, based at the Oxford Centre for Diabetes, Endocrinology and Metabolism and at the Wellcome Trust Centre for Human Genetics, is exploring how these advances in genetics and genomics can be used to improve the clinical management of diabetes and obesity.

< Back

Dr Paul Jenkins MA BChir MD FRCP
Reader in Endocrine Oncology, Honorary Consultant Physician, St Bartholomew’s Hospital, Queen Mary School of Medicine and Dentistry, University of London. He is Medical Advisor of the European Scanning Centre, which is one of only two centres in the UK to use an Electron Beam CT (EBCT) scanner. Paul is a specialist in endocrinology (hormones), particularly growth disorders, and is a leading researcher into how hormones influence our predisposition to a number of cancers, especially cancer of the colon. He leads an active research team and has published over 60 research papers in the field of hormones and genetic actions in the human body. In addition he has written numerous chapters for textbooks, and is regularly invited to present his work at national and international meetings. He has a special interest in the role of genetics in disease prevention and ageing.
< Back

Please note: topics, times and speakers may change from those listed.